| Year |
Citation |
Score |
| 2023 |
Gedik ME, Saatci O, Oberholtzer N, Uner M, Akbulut O, Cetin M, Aras M, Ibis K, Caliskan B, Banoglu E, Wiemann S, Uner A, Aksoy S, Mehrotra S, Sahin O. Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer. Biorxiv : the Preprint Server For Biology. PMID 37745348 DOI: 10.1101/2023.09.12.557273 |
0.768 |
|
| 2023 |
Olğaç A, Çapan İ, Dahlke P, Jordan PM, Werz O, Banoglu E. Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein. Acs Omega. 8: 31293-31304. PMID 37663492 DOI: 10.1021/acsomega.3c03682 |
0.828 |
|
| 2023 |
Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D, O'Quinn EC, Romeo MJ, Caliskan B, Banoglu E, Aksoy S, Uner A, Sahin O. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death and Differentiation. PMID 36864125 DOI: 10.1038/s41418-023-01140-1 |
0.716 |
|
| 2023 |
Gur Maz T, Koc B, Jordan PM, İbiş K, Çalışkan B, Werz O, Banoglu E. Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors. Acs Omega. 8: 2445-2454. PMID 36687110 DOI: 10.1021/acsomega.2c06936 |
0.852 |
|
| 2022 |
Turanlı S, Ergül AG, Jordan PM, Olğaç A, Çalışkan B, Werz O, Banoglu E. Quinazoline-4(3)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition. Acs Omega. 7: 36354-36365. PMID 36278102 DOI: 10.1021/acsomega.2c04039 |
0.846 |
|
| 2022 |
Turanlı S, Nalbat E, Lengerli D, İbiş K, Güntekin Ergün S, Akhan Güzelcan E, Muyan M, Cetin-Atalay R, Çalışkan B, Banoglu E. Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with Growth Inhibitory and Antitumor Activity. Acs Omega. 7: 36206-36226. PMID 36278052 DOI: 10.1021/acsomega.2c03405 |
0.83 |
|
| 2022 |
Lengerli D, Ibis K, Nural Y, Banoglu E. The 1,2,3-triazole "all-in-one" ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opinion On Drug Discovery. PMID 36164263 DOI: 10.1080/17460441.2022.2129613 |
0.767 |
|
| 2022 |
Gur Maz T, Turanlı S, Caliskan HB, Çalışkan B, Banoglu E. Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors. Archiv Der Pharmazie. e2200082. PMID 35500130 DOI: 10.1002/ardp.202200082 |
0.807 |
|
| 2022 |
Çapan İ, Jordan PM, Olğaç A, Çalışkan B, Kretzer C, Werz O, Banoglu E. Discovery and optimization of piperazine urea derivatives as soluble epoxide hydrolase (sEH) inhibitors. Chemmedchem. PMID 35466565 DOI: 10.1002/cmdc.202200137 |
0.827 |
|
| 2022 |
Banoglu E, Ercanlı T, Gür Maz T, Vullo D, Bonardi A, Gratteri P, Supuran CT. A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors. Chemmedchem. e202200056. PMID 35266325 DOI: 10.1002/cmdc.202200056 |
0.324 |
|
| 2022 |
Ergül AG, Maz TG, Kretzer C, Olğaç A, Jordan PM, Çalışkan B, Werz O, Banoglu E. Novel potent benzimidazole-based microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C synthase. European Journal of Medicinal Chemistry. 231: 114167. PMID 35152061 DOI: 10.1016/j.ejmech.2022.114167 |
0.845 |
|
| 2021 |
İbiş K, Nalbat E, Çalışkan B, Kahraman DC, Cetin-Atalay R, Banoglu E. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells. European Journal of Medicinal Chemistry. 221: 113489. PMID 33951549 DOI: 10.1016/j.ejmech.2021.113489 |
0.809 |
|
| 2021 |
Gürses T, Olğaç A, Garscha U, Gür Maz T, Bal NB, Uludağ O, Çalışkan B, Schubert US, Werz O, Banoglu E. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy. Bioorganic Chemistry. 112: 104861. PMID 33826984 DOI: 10.1016/j.bioorg.2021.104861 |
0.837 |
|
| 2020 |
Shkodra-Pula B, Kretzer C, Jordan PM, Klemm P, Koeberle A, Pretzel D, Banoglu E, Lorkowski S, Wallert M, Höppener S, Stumpf S, Vollrath A, Schubert S, Werz O, Schubert US. Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity. Journal of Nanobiotechnology. 18: 73. PMID 32408877 DOI: 10.1186/S12951-020-00620-7 |
0.478 |
|
| 2020 |
Akbulut O, Lengerli D, Saatci O, Duman E, Seker UOS, Isik A, Akyol A, Caliskan B, Banoglu E, Şahin Ö. A Highly Potent TACC3 Inhibitor as a Novel Anti-cancer Drug Candidate. Molecular Cancer Therapeutics. PMID 32217742 DOI: 10.1158/1535-7163.Mct-19-0957 |
0.756 |
|
| 2020 |
Olgac A, Carotti A, Kretzer C, Zergiebel S, Seeling A, Garscha U, Werz O, Macchiarulo A, Banoglu E. Discovery of novel 5-lipoxygenase-activating protein (FLAP) inhibitors by exploiting a multistep virtual screening protocol. Journal of Chemical Information and Modeling. PMID 32045233 DOI: 10.1021/Acs.Jcim.9B00941 |
0.843 |
|
| 2020 |
Özdemir A, Turanli S, Çalişkan B, Arka M, Banoglu E. Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells Pharmaceutical Chemistry Journal. 53: 1036-1046. DOI: 10.1007/S11094-020-02119-9 |
0.778 |
|
| 2019 |
Uslu AG, Gür Maz T, Nocentini A, Banoglu E, Supuran CT, Çalışkan B. Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors. Bioorganic Chemistry. 95: 103544. PMID 31915112 DOI: 10.1016/J.Bioorg.2019.103544 |
0.767 |
|
| 2019 |
Boccellino M, Donniacuo M, Bruno F, Rinaldi B, Quagliuolo L, Ambruosi M, Pace S, De Rosa M, Olgaç A, Banoglu E, Alessio N, Massa A, Kahn H, Werz O, Fiorentino A, et al. Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors. European Journal of Medicinal Chemistry. 180: 637-647. PMID 31351395 DOI: 10.1016/J.Ejmech.2019.07.033 |
0.831 |
|
| 2019 |
Mostarda S, Gür Maz T, Piccinno A, Cerra B, Banoglu E. Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions. Molecules (Basel, Switzerland). 24. PMID 31277341 DOI: 10.3390/Molecules24132447 |
0.302 |
|
| 2019 |
Shekfeh S, Çalışkan B, Fischer K, Yalçın T, Garscha U, Werz O, Banoglu E. A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E Synthase-1 (mPGES-1) Inhibitors. Chemmedchem. 14: 273-281. PMID 30537167 DOI: 10.1002/Cmdc.201800701 |
0.806 |
|
| 2019 |
Akbulut O, Lengerli D, Saatci O, Duman E, Seker U, Caliskan B, Banoglu E, Sahin O. Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer Cancer Research. 79: 3871-3871. DOI: 10.1158/1538-7445.Am2019-3871 |
0.775 |
|
| 2018 |
Çalışkan B, Sinoplu E, İbiş K, Akhan Güzelcan E, Çetin Atalay R, Banoglu E. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 33: 1352-1361. PMID 30251900 DOI: 10.1080/14756366.2018.1504041 |
0.801 |
|
| 2018 |
Bruno F, Errico S, Pace S, Nawrozkij MB, Mkrtchyan AS, Guida F, Maisto R, Olgaç A, D'Amico M, Maione S, De Rosa M, Banoglu E, Werz O, Fiorentino A, Filosa R. Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation. European Journal of Medicinal Chemistry. 155: 946-960. PMID 30015253 DOI: 10.1016/J.Ejmech.2018.05.041 |
0.832 |
|
| 2018 |
Gür ZT, Çalışkan B, Garscha U, Olgaç A, Schubert US, Gerstmeier J, Werz O, Banoglu E. Identification of multi-target inhibitors of leukotriene and prostaglandin Ebiosynthesis by structural tuning of the FLAP inhibitor BRP-7. European Journal of Medicinal Chemistry. 150: 876-899. PMID 29597170 DOI: 10.1016/J.Ejmech.2018.03.045 |
0.847 |
|
| 2018 |
Gür ZT, Şenol FS, Shekfeh S, Orhan İE, Banoğlu E, Çalişkan B. Novel Piperazine Amides of Cinnamic Acid Derivatives as Tyrosinase Inhibitors Letters in Drug Design & Discovery. 16: 36-44. DOI: 10.2174/1570180815666180420105652 |
0.822 |
|
| 2017 |
Olğaç A, Orhan IE, Banoglu E. The potential role of in silico approaches to identify novel bioactive molecules from natural resources. Future Medicinal Chemistry. 9: 1665-1686. PMID 28841048 DOI: 10.4155/Fmc-2017-0124 |
0.766 |
|
| 2017 |
Gür ZT, Çalışkan B, Banoglu E. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis. European Journal of Medicinal Chemistry. PMID 28784429 DOI: 10.1016/J.Ejmech.2017.07.019 |
0.787 |
|
| 2017 |
Orhan IE, Senol FS, Shekfeh S, Skalicka-Wozniak K, Banoglu E. Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. PMID 28286309 DOI: 10.1016/J.Fct.2017.03.016 |
0.432 |
|
| 2016 |
Garscha U, Voelker S, Pace S, Gerstmeier J, Emini B, Liening S, Rossi A, Weinigel C, Rummler S, Schubert US, E Scriba GK, Çelikoğlu E, Çalışkan B, Banoglu E, Sautebin L, et al. BRP-187: a potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase / 5-lipoxygenase-activating protein (FLAP) complex assembly. Biochemical Pharmacology. PMID 27592027 DOI: 10.1016/J.Bcp.2016.08.023 |
0.798 |
|
| 2016 |
Levent S, Gerstmeier J, Olgaç A, Nikels F, Garscha U, Carotti A, Macchiarulo A, Werz O, Banoglu E, Çalışkan B. Synthesis and biological evaluation of C(5)-substituted derivatives of leukotriene biosynthesis inhibitor BRP-7. European Journal of Medicinal Chemistry. 122: 510-519. PMID 27423639 DOI: 10.1016/J.Ejmech.2016.07.004 |
0.809 |
|
| 2016 |
Banoglu E, Çelikoğlu E, Völker S, Olgaç A, Gerstmeier J, Garscha U, Çalışkan B, Schubert US, Carotti A, Macchiarulo A, Werz O. 4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP). European Journal of Medicinal Chemistry. 113: 1-10. PMID 26922224 DOI: 10.1016/J.Ejmech.2016.02.027 |
0.84 |
|
| 2014 |
Pirol ŞC, Çalişkan B, Durmaz I, Atalay R, Banoglu E. Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines European Journal of Medicinal Chemistry. 87: 140-149. PMID 25247770 DOI: 10.1016/J.Ejmech.2014.09.056 |
0.771 |
|
| 2014 |
Alaşalvar C, Soylu MS, Ünver H, Ocak İskeleli N, Yildiz M, Çiftçi M, Banoğlu E. Crystal structure and DFT calculations of 5-(4-Chlorophenyl)-1-(6-methoxypyridazin-3-yl)-1H-pyrazole-3-carboxylic acid. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 132: 555-62. PMID 24892534 DOI: 10.1016/J.Saa.2014.05.014 |
0.353 |
|
| 2014 |
Baytas SN, Inceler N, Yilmaz A, Olgac A, Menevse S, Banoglu E, Hamel E, Bortolozzi R, Viola G. Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry. 22: 3096-104. PMID 24816066 DOI: 10.1016/J.Bmc.2014.04.027 |
0.826 |
|
| 2014 |
Pergola C, Gerstmeier J, Mönch B, Çalışkan B, Luderer S, Weinigel C, Barz D, Maczewsky J, Pace S, Rossi A, Sautebin L, Banoglu E, Werz O. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). British Journal of Pharmacology. 171: 3051-64. PMID 24641614 DOI: 10.1111/Bph.12625 |
0.511 |
|
| 2014 |
Sardella R, Levent S, Ianni F, Çalişkan B, Gerstmeier J, Pergola C, Werz O, Banoglu E, Natalini B. Chromatographic separation and biological evaluation of benzimidazole derivative enantiomers as inhibitors of leukotriene biosynthesis Journal of Pharmaceutical and Biomedical Analysis. 89: 88-92. PMID 24270288 DOI: 10.1016/J.Jpba.2013.10.039 |
0.73 |
|
| 2013 |
Levent S, Çalışkan B, Çiftçi M, Özkan Y, Yenicesu I, Ünver H, Banoglu E. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation. European Journal of Medicinal Chemistry. 64: 42-53. PMID 23639653 DOI: 10.1016/J.Ejmech.2013.03.048 |
0.769 |
|
| 2013 |
Calışkan B, Banoglu E. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors. Expert Opinion On Drug Discovery. 8: 49-63. PMID 23095029 DOI: 10.1517/17460441.2013.735228 |
0.759 |
|
| 2012 |
Eren G, Macchiarulo A, Banoglu E. From Molecular Docking to 3D-Quantitative Structure-Activity Relationships (3D-QSAR): Insights into the Binding Mode of 5-Lipoxygenase Inhibitors. Molecular Informatics. 31: 123-34. PMID 27476957 DOI: 10.1002/Minf.201100101 |
0.678 |
|
| 2012 |
Banoglu E, Çalişkan B, Luderer S, Eren G, Özkan Y, Altenhofen W, Weinigel C, Barz D, Gerstmeier J, Pergola C, Werz O. Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP). Bioorganic & Medicinal Chemistry. 20: 3728-41. PMID 22607880 DOI: 10.1016/J.Bmc.2012.04.048 |
0.838 |
|
| 2012 |
Çalışkan B, Yılmaz A, Evren İ, Menevşe S, Uludag O, Banoglu E. Synthesis and evaluation of analgesic, anti-inflammatory, and anticancer activities of new pyrazole-3(5)-carboxylic acid derivatives Medicinal Chemistry Research. 22: 782-793. DOI: 10.1007/S00044-012-0072-4 |
0.785 |
|
| 2011 |
Ergün BC, Coban T, Onurdag FK, Banoglu E. Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid. Archives of Pharmacal Research. 34: 1251-61. PMID 21910045 DOI: 10.1007/S12272-011-0803-Y |
0.452 |
|
| 2011 |
Calışkan B, Luderer S, Özkan Y, Werz O, Banoglu E. Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils. European Journal of Medicinal Chemistry. 46: 5021-33. PMID 21868137 DOI: 10.1016/J.Ejmech.2011.08.009 |
0.828 |
|
| 2010 |
Ergün BC, Nuñez MT, Labeaga L, Ledo F, Darlington J, Bain G, Cakir B, Banoglu E. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation. Arzneimittel-Forschung. 60: 497-505. PMID 20863006 DOI: 10.1055/S-0031-1296318 |
0.557 |
|
| 2010 |
Eren G, Unlü S, Nuñez MT, Labeaga L, Ledo F, Entrena A, Banoğlu E, Costantino G, Sahin MF. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 18: 6367-76. PMID 20692174 DOI: 10.1016/J.Bmc.2010.07.009 |
0.536 |
|
| 2009 |
Dündar Y, Unlü S, Banoğlu E, Entrena A, Costantino G, Nuñez MT, Nunez MT, Labeaga L, Ledo F, Sahin MF, Noyanalpan N. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. European Journal of Medicinal Chemistry. 44: 1830-7. PMID 19084295 DOI: 10.1016/J.Ejmech.2008.10.039 |
0.564 |
|
| 2009 |
Dündar Y, Ünlü S, Banoğlu E, Entrena A, Costantino G, Nunez M, Ledo F, Fethi Şahin M, Noyanalpan N. Corrigendum to “Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors” [Eur. J. Med. Chem. 44 (2009) 1830–1837] European Journal of Medicinal Chemistry. 44: 4785. DOI: 10.1016/J.Ejmech.2009.05.020 |
0.325 |
|
| 2009 |
Önkol T, Banoglu E, Dündar Y, Küpeli E, Şahin MF. Amide derivatives of [6-acyl-2-benzothiazolinon-3-yl] acetic acids as potential analgesic and anti-inflammatory compounds Medicinal Chemistry Research. 19: 11-24. DOI: 10.1007/S00044-009-9168-X |
0.487 |
|
| 2009 |
Duendar Y, Uenlue S, Banoglu E, Entrena A, Costantino G, Nunez M, Ledo F, Sahin MF, Noyanalpan N. ChemInform Abstract: Synthesis and Biological Evaluation of 4,5-Diphenyloxazolone Derivatives on Route Towards Selective COX-2 Inhibitors. Cheminform. 40. DOI: 10.1002/CHIN.200934123 |
0.317 |
|
| 2008 |
Caliskan-Ergün B, Süküroğlu M, Coban T, Banoğlu E, Suzen S. Screening and evaluation of antioxidant activity of some pyridazine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 23: 225-9. PMID 18343908 DOI: 10.1080/14756360701475167 |
0.431 |
|
| 2007 |
Unlü S, Banoglu E, Ito S, Niiya T, Eren G, Okçelik B, Sahin MF. Synthesis, characterization and preliminary screening of regioisomeric 1-(3-pyridazinyl)-3-arylpyrazole and 1-(3-pyridazinyl)-5-arylpyrazole derivatives towards cyclooxygenase inhibition. Journal of Enzyme Inhibition and Medicinal Chemistry. 22: 351-61. PMID 17674817 DOI: 10.1080/14756360601073468 |
0.43 |
|
| 2007 |
Şüküroğlu M, Çalişkan-Ergün B, Das-Evcimen N, Sarikaya M, Banoğlu E, Suzen S. Screening and evaluation of rat kidney aldose reductase inhibitory activity of some pyridazine derivatives Medicinal Chemistry Research. 15: 443-451. DOI: 10.1007/S00044-006-0021-1 |
0.43 |
|
| 2006 |
Süküroglu M, Küpeli E, Banoğlu E, Unlü S, Yeşilada E, Sahin MF. Synthesis and analgesic activity of some 4,6-disubstituted-3(2H)-pyridazinone derivatives. Arzneimittel-Forschung. 56: 337-45. PMID 16821644 DOI: 10.1055/S-0031-1296731 |
0.423 |
|
| 2005 |
Süküroglu M, Caliskan Ergün B, Unlü S, Sahin MF, Küpeli E, Yesilada E, Banoglu E. Synthesis, analgesic, and anti-inflammatory activities of [6-(3,5-dimethyl-4-chloropyrazole-1-yl)-3(2H)-pyridazinon-2-yl]acetamides. Archives of Pharmacal Research. 28: 509-17. PMID 15974435 DOI: 10.1007/Bf02977751 |
0.463 |
|
| 2004 |
Banoglu E, Akoğlu C, Unlü S, Küpeli E, Yeşilada E, Sahin MF. Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Archiv Der Pharmazie. 337: 7-14. PMID 14760622 DOI: 10.1002/Ardp.200200738 |
0.521 |
|
| 2003 |
Okçelik B, Unlü S, Banoglu E, Küpeli E, Yeşilada E, Sahin MF. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity. Archiv Der Pharmazie. 336: 406-12. PMID 14528488 DOI: 10.1002/Ardp.200300778 |
0.507 |
|
| 2003 |
Banoglu E, Okçelik B, Kupeli E, Unlü S, Yeşilada E, Amat M, Caturla JF, Sahin MF. Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Archiv Der Pharmazie. 336: 251-7. PMID 12916060 DOI: 10.1002/Ardp.200300723 |
0.511 |
|
| 2002 |
Banoglu E, King RS. Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate European Journal of Drug Metabolism and Pharmacokinetics. 27: 135-140. PMID 12064372 DOI: 10.1007/Bf03190428 |
0.346 |
|
| 2001 |
Banoglu E, Jha GG, King RS. Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate European Journal of Drug Metabolism and Pharmacokinetics. 26: 235-240. PMID 11808865 DOI: 10.1007/Bf03226377 |
0.314 |
|
| 2001 |
Banoglu E. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Current Drug Metabolism. 1: 1-30. PMID 11467078 DOI: 10.2174/1389200003339234 |
0.361 |
|
| Show low-probability matches. |